×
About 8,134 results

ALLMedicine™ Prostatic Hyperplasia Center

Research & Reviews  3,295 results

Ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP): outcomes on ...
https://doi.org/10.1007/s00345-020-03442-2
World Journal of Urology; Bozzini G, Berti L et. al.

Sep 15th, 2020 - To assess the effects of a new ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP) technique on sexual functions and micturition, in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) a...

The effectiveness and safety of moxibustion for treating benign prostatic hyperplasia: ...
https://doi.org/10.1097/MD.0000000000022006
Medicine Chen H, Li Q et. al.

Sep 9th, 2020 - Benign prostatic hyperplasia (BPH) is a disease of the urinary system. It is common in middle-aged and elderly men. Moxibustion is widely used to manage BPH and the associated lower urinary tract symptoms, but there is still lack of systematic rev...

Item Response Theory Modeling of the International Prostate Symptom Score in Patients w...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452927
The AAPS Journal; Lyauk YK, Jonker DM et. al.

Aug 28th, 2020 - Item response theory (IRT) was used to characterize the time course of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH-LUTS) measured by item-level International Prostate Symptom Scores (IPSS). The Fisher information content ...

Urinary and sexual function after treatment with temporary implantable nitinol device (...
https://doi.org/10.1007/s00345-020-03418-2
World Journal of Urology; De Nunzio C, Cantiello F et. al.

Aug 25th, 2020 - To evaluate the functional outcomes as they relate to the preservation of urinary continence and sexual function after treatment with the temporarily implanted nitinol device (iTind; Medi-Tate Ltd, Israel); a novel minimally invasive treatment for...

Holmium Laser Enucleation versus Bipolar Plasmakinetic Resection for Management of Lowe...
https://doi.org/10.1089/end.2020.0636
Journal of Endourology; Habib E, ElSheemy MS et. al.

Aug 24th, 2020 - To compare safety and efficacy of holmium laser enucleation (HoLEP) versus bipolar plasmakinetic resection (BPRP) of prostate in management of large sized (≥75gm) benign prostatic hyperplasia (BPH). This randomised controlled trial recruited 145 s...

see more →

Guidelines  5 results

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.

May 6th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1016/j.juro.2018.05.048
The Journal of Urology; Foster HE, Barry MJ et. al.

May 18th, 2018 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference on the effective evidence-base...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
http://www.auanet.org/guidelines/benign-prostatic-hyperplasia/lower-urinary-tract-symptoms-(2018)
Harris E. Foster

Apr 30th, 2018 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the.

Korean clinical practice guideline for benign prostatic hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.

Mar 11th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

Outline of JUA clinical guidelines for benign prostatic hyperplasia.
https://doi.org/10.1111/j.1442-2042.2011.02860.x
International Journal of Urology : Official Journal of the Japanese Urological Association; Homma Y, Gotoh M et. al.

Nov 4th, 2011 - The Japanese Urological Association has developed Clinical Guidelines for Benign Prostatic Hyperplasia (BPH) for men with suspected BPH, which have been abridged and translated into English. This article is a shortened version of the English trans...

see more →

Drugs  731 results see all →

Clinicaltrials.gov  4,065 results

Tadalafil - tadalafil tablet-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c835a34a-9bae-4d88-b951-1b78ab92f388

Sep 16th, 2020 - Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia (BPH) (1.2) ED and the signs and symptoms of BPH (ED/BPH) (1.3) If tadalafil...

Ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP): outcomes on ...
https://doi.org/10.1007/s00345-020-03442-2
World Journal of Urology; Bozzini G, Berti L et. al.

Sep 15th, 2020 - To assess the effects of a new ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP) technique on sexual functions and micturition, in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) a...

The effectiveness and safety of moxibustion for treating benign prostatic hyperplasia: ...
https://doi.org/10.1097/MD.0000000000022006
Medicine Chen H, Li Q et. al.

Sep 9th, 2020 - Benign prostatic hyperplasia (BPH) is a disease of the urinary system. It is common in middle-aged and elderly men. Moxibustion is widely used to manage BPH and the associated lower urinary tract symptoms, but there is still lack of systematic rev...

Terazosin - terazosin hydrochloride capsule-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=521e4aad-c6ec-4410-867f-dd9ecc08d5b2

Sep 1st, 2020 - Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when tr...

Tamsulosin hydrochloride - tamsulosin hydrochloride capsule-Preferred Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18a050dd-b0f0-43dd-9aaf-56ab3c0aea3e

Aug 31st, 2020 - Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. •...

see more →

News  25 results

Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements
https://www.mdedge.com/ccjm/article/178017/mens-health/mens-health-2018-bph-prostate-cancer-erectile-dysfunction?channel=325
Alexander Chaitoff, MPH, T. Colin Killeen, DO et. al.

Nov 1st, 2018 - Primary care physicians are tasked with a wide variety of issues affecting men. This article reviews the latest research in 4 areas of men’s health commonly addressed in primary care: Medical management of benign prostatic hyperplasia (BPH) Prosta.

Benign prostatic hyperplasia: Evaluation and medical management in primary care
https://www.mdedge.com/ccjm/article/121347/drug-therapy/benign-prostatic-hyperplasia-evaluation-and-medical-management?channel=133
Raman Unnikrishnan, MD, Nima Almassi, MD et. al.

Jan 1st, 2017 - Primary care physicians are uniquely positioned to screen for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms, to perform the initial diagnostic workup, and to start medical therapy in uncomplicated cases. Effective medical the.

Finding Value in the Cost of BPH Care
https://www.medpagetoday.com/urology/bph/50508

Mar 16th, 2015 - Action Points Note that this cost analysis of benign prostatic hypertrophy treatment finds that, depending on treatment strategy selected, costs can vary by as much as 400%. Be aware that the methodology used in this study is relatively novel and ...

NSAIDs for BPH
https://www.mdedge.com/internalmedicine/article/58200/mens-health/nsaids-bph
Jon O. Ebbert, MD

Mar 28th, 2013 - Benign prostatic hyperplasia is an uncommon cause of mortality but a common cause of morbidity. More than 80% of men aged older than 80 years have histologic evidence of benign prostatic hyperplasia (BPH).

Drug-PSA Combo May Pinpoint Prostate Cancer
https://www.medpagetoday.com/hematologyoncology/prostatecancer/34125

Aug 9th, 2012 - Action Points Treatment with 5α-reductase inhibitors enhanced the usefulness of prostate specific antigen (PSA) testing in men with persistently increased serum PSA, but negative biopsy results. Point out that the magnitude of change in serum PSA ...

see more →

Patient Education  13 results see all →